EBSCO Logo
Connecting you to content on EBSCOhost
Results
Title

Pseudoprogression on PSMA PET imaging of a mCRPC patient under anti-PD1 treatment.

Authors

Costa, Larissa Bastos; Queiroz, Marcelo Araujo; Barbosa, Felipe de Galiza; Nunes, Rafael Fernandes; Marin, José Flávio Gomes; Dzik, Carlos; Buchpiguel, Carlos Alberto

Abstract

The article presents a case study of an 85-year-old patient with developed Gleason 10 PCa and was treated with brachytherapy and undergone salvage prostatectomy. The patient was diagnosed with metastatic pelvic nodal disease and underwent microsatellite instability (MSI)-H tumor biopsy leading to the start of anti-PD1 therapy with pembrolizumab. The also undergone sets of prostate-specific membrane antigen (PSMA-PET) imaging.

Subjects

CANCER diagnosis; CANCER treatment; PROSTATE-specific membrane antigen; IMMUNOTHERAPY; PEMBROLIZUMAB

Publication

European Journal of Nuclear Medicine & Molecular Imaging, 2019, Vol 46, Issue 7, p1576

ISSN

1619-7070

Publication type

Academic Journal

DOI

10.1007/s00259-019-04328-1

EBSCO Connect | Privacy policy | Terms of use | Copyright | Manage my cookies
Journals | Subjects | Sitemap
© 2025 EBSCO Industries, Inc. All rights reserved